Accessibility Menu
Aspire Biopharma logo

Aspire Biopharma(NASDAQ) ASBPW

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)-96%
5 YearN/A
1 Year-67%
1 Month-19%
$0.02
+7.14%
+0.00Today
Aspire Biopharma last closing stock price
MetricPriceDate
Last closeUSD 0.022026-08-28
Aspire Biopharma stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+14.5%USD 0.012026-08-21
1 month-18.92%USD 0.022026-07-29
3 month+7.14%USD 0.012026-05-29
Year to date-9.09%USD 0.022025-12-31
1 year-66.67%USD 0.052025-08-28
3 year-85%USD 0.102023-08-29
Since inception-95.71%USD 0.352022-04-11

Aspire Biopharma Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$97.66K

Net Income (TTM)

-$11.05M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.26 (Low)

Price

$0.02

Volume

8,653

Open

$0.01

Previous Close

$0.02

Daily Range

$0.01 - $0.02

52-Week Range

$0.01 - $0.07

Estimated Earnings Date

N/A

ASBPW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Aspire Biopharma

Aspire Biopharma Holdings, Inc. is a biotechnology company focused on innovative diagnostic approaches and molecular analysis. The company aims to develop precise testing tools for identifying various illnesses, leveraging advancements in genetic and biochemical science to meet healthcare needs.

Products and Services
  • Innovative diagnostic tools for illness identification
  • Molecular analysis services for healthcare and life sciences
  • Research and development in genetic and biochemical sciences
Growth Outlook
  • Recent quarterly revenue increased to $28,353, showing potential for growth
  • Cash and cash equivalents reached $5.86 million, providing operational flexibility
  • Current ratio of 2.26 indicates strong short-term financial health
Financial Highlights
  • Trailing twelve months revenue of $42,261 reflects upward momentum
  • Net income for Q1 2026 was -$3,222,892, indicating ongoing investment in growth
  • Operating expenses totaled $1,651,919 in Q1 2026, highlighting R&D focus
AI Generated • Aug 5, 2026

Industry

Pharmaceuticals

Sector

Health Care

Headquarters

Estero, FL 33928, US

ASBPW Financials

Key Financial Metrics (TTM)

Gross Margin

18.35%

Operating Margin

-7259.92%

Net Income Margin

-11314.24%

Return on Equity

1993.26%

Return on Capital

N/A

Return on Assets

-81.60%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

8.65K

Avg. Volume

22.66K

Financials (TTM)

Gross Profit

$17.92K

Operating Income

-$7.09M

EBITDA

$3.29M

Operating Cash Flow

-$7.19M

Capital Expenditure

$0.00

Free Cash Flow

-$7.19M

Cash & ST Invst.

$12.17M

Total Debt

$0.00

Aspire Biopharma Performance Analysis

Aspire Biopharma sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30N/A
Q42025-12-31119.5%
Q12026-03-31565.4%
Q22026-06-30122.6%
Aspire Biopharma sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-307.5%
Q42025-12-31-111.4%
Q12026-03-3131.4%
Q22026-06-3043.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$63.10K

N/A

Gross Profit

$12.29K

N/A

Gross Margin

19.47%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

2

N/A

Net Income

-$1.27M

+36.0%

EBITDA

-$2.45M

-68.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$12.17M

+5799.7%

Total Debt

$0.00

-100.0%

Accounts Receivable

$0.00

N/A

Inventory

$288.45K

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-81.60%

N/A

Return on Invested Capital

-59.81%

N/A

Free Cash Flow

-$2.12M

-85.5%

Operating Cash Flow

-$2.12M

-85.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PTIXProtagenic Therapeutics, Inc.
$1.20+22.44%
REVBRevelation Biosciences, Inc.
$1.00-4.76%
PBMPsyence Biomedical Ltd.
$4.34+3.09%
ARTLArtelo Biosciences, Inc.
$6.36+6.63%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About ASBPW

What is the current price of Aspire Biopharma?

Aspire Biopharma is trading at $0.02 per share.

What is the 52-week range for Aspire Biopharma?

Over the past 52 weeks, Aspire Biopharma has traded between $0.01 and $0.07.

How much debt does Aspire Biopharma have?

Aspire Biopharma total debt is unavailable.

How much cash does Aspire Biopharma have on hand?

Aspire Biopharma does not have cash on hand data available.

What is Aspire Biopharma’s dividend yield?

Aspire Biopharma does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services